Stay updated on Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page.

Latest updates to the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page has removed a citation regarding a study on tumor-associated B7-H1 and its role in T-cell apoptosis, which may impact the credibility of the content related to immune evasion mechanisms.SummaryDifference0.1%
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check45 days agoChange DetectedThe page has undergone significant updates, including the addition of new collaborators and investigators, as well as a revision update. Notably, the detailed inclusion and exclusion criteria for the study have been removed, which may impact the clarity of the study's eligibility requirements.SummaryDifference21%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check60 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page.